[HTML][HTML] Immunomodulatory effects of probiotics on COVID-19 infection by targeting the gut–lung axis microbial cross-talk
KD Synodinou, MD Nikolaki, K Triantafyllou, AN Kasti - Microorganisms, 2022 - mdpi.com
The ecosystem of the human gastrointestinal tract, named gut microbiota, represents the
most thoroughly mapped ecosystem. Perturbations on bacterial populations cause …
most thoroughly mapped ecosystem. Perturbations on bacterial populations cause …
Cross-talk between immune system and microbiota in COVID-19
S Baradaran Ghavami, M Pourhamzeh… - Expert review of …, 2021 - Taylor & Francis
Introduction Human gut microbiota plays a crucial role in providing protective responses
against pathogens, particularly by regulating immune system homeostasis. There is a …
against pathogens, particularly by regulating immune system homeostasis. There is a …
[HTML][HTML] Effective regulation of gut microbiota with probiotics and prebiotics may prevent or alleviate COVID-19 through the gut-lung axis
L Xu, CS Yang, Y Liu, X Zhang - Frontiers in Pharmacology, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) can disrupt the gut microbiota balance, and patients
usually have intestinal disorders. The intestine is the largest immune organ of the human …
usually have intestinal disorders. The intestine is the largest immune organ of the human …
[HTML][HTML] Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19
T Amrouche, ML Chikindas - AIMS microbiology, 2022 - ncbi.nlm.nih.gov
COVID-19 pandemic is currently causing high mortality and economic crisis, and several
drugs-based therapeutic strategies and vaccines are unfortunately used with little efficiency …
drugs-based therapeutic strategies and vaccines are unfortunately used with little efficiency …
[HTML][HTML] Microbiota modulation of the gut-lung axis in COVID-19
GLV de Oliveira, CNS Oliveira, CF Pinzan… - Frontiers in …, 2021 - frontiersin.org
COVID-19 is an infectious disease caused by the Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2), and according to the World Health Organization (WHO), to …
Coronavirus-2 (SARS-CoV-2), and according to the World Health Organization (WHO), to …
[HTML][HTML] Gut microbiota dysbiosis and COVID-19: Possible links
B Aktas - Comprehensive Gut Microbiota, 2022 - ncbi.nlm.nih.gov
Microbiota in the gastrointestinal system is a major determinant in health and disease status
with its influence on immunity. Bidirectional relationship between gut microbiota and host …
with its influence on immunity. Bidirectional relationship between gut microbiota and host …
[HTML][HTML] Oral probiotics in coronavirus disease 2019: Connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials
Defined as helpful live bacteria that can provide medical advantages to the host when
administered in tolerable amounts, oral probiotics might be worth considering as a possible …
administered in tolerable amounts, oral probiotics might be worth considering as a possible …
[HTML][HTML] Effect of probiotics as an immune modulator for the management of COVID-19
COVID-19, an acute respiratory viral infection conveyed by pneumonia caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected millions of individuals …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected millions of individuals …
[HTML][HTML] The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes
J Chen, L Vitetta - Frontiers in Bioscience-Scholar, 2022 - imrpress.com
The main entry point of SARS-CoV-2 is the respiratory tract and as such immune defence in
this site determines if the virus will spill-over to the systemic circulation and circulate and …
this site determines if the virus will spill-over to the systemic circulation and circulate and …
Targeting microbiome: an alternative strategy for fighting SARS-CoV-2 infection
O Spagnolello, C Pinacchio, L Santinelli, P Vassalini… - Chemotherapy, 2021 - karger.com
Respiratory and gastrointestinal symptoms are the predominant clinical manifestations of the
coronavirus disease 2019 (COVID-19). Infecting intestinal epithelial cells, the severe acute …
coronavirus disease 2019 (COVID-19). Infecting intestinal epithelial cells, the severe acute …
相关搜索
- lung axis immunomodulatory effects
- lung axis oral probiotics
- lung axis secondary infection
- covid 19 probiotics and prebiotics
- lung axis coronavirus disease
- covid 19 inflammasome modulation
- lung axis viral pathogenesis
- secondary infection oral probiotics
- covid 19 effective regulation
- covid 19 microbiota modulation